LAVA Therapeutics N.V. (LVTX) Fundamentals

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
SHARE INFORMATION
Market Cap$ 192,173,226
Shares Outstanding26,289,087
Float9,969,424
Percent Float37.92%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 5,730,450
Latest Fiscal EPS$ -13.42
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions6
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months808
Institutional Holdings Percent1.5%
Institutional Sold Previous 3 Months2,086
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 7.89
52 Week Low$ 2.28
52 Week High Change$ 6.40
21 Day Moving Average$ 5.4102
21 Day Extended Moving Average$ 5.5092
50 Day Moving Average$ 4.6099
50 Day Extended Moving Average$ 4.71
200 Day Moving Average$ 3.6663
200 Day Extended Moving Average$ 4.3054
10 Day Average Volume37,594
20 Day Average Volume34,879
30 Day Average Volume37,904
50 Day Average Volume1,051,100
Alpha-0.017223
Beta-1.0244
Standard Deviation0.260134
R20.050099
7 Day Price Change$ 1.56
7 Day Percent Change27.13%
21 Day Price Change$ 2.36
21 Day Percent Change47.68%
30 Day Price Change$ 2.73
30 Day Percent Change59.61%
Month to Date Price Change$ 1.80
Month to Date Percent Change32.67%
Quarter to Date Price Change$ 2.74
Quarter to Date Percent Change59.96%
180 Day Price Change$ 4.28
180 Day Percent Change141.25%
200 Day Price Change$ 3.50
200 Day Percent Change91.86%
Year to Date Price Change$ 1.81
Year to Date Percent Change32.91%

LAVA Therapeutics N.V. (LVTX) Key Ratios

PROFITABILITY
EBIT Margin-192.2%
EBITDA Margin-188.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 18,250,492
Revenue Per Share$ 0.6942
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.10
Total Debt To Equity0.10
Int Coverage-71.20
Current Ratio8.30
Leverage Ratio1.30
Quick Ratio8.20
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-5.10
Enterprise Value$ 104,082,225
Price to Sales10.5298
Price to Free Cash-4.50
PE High Last 5 Years0.00
Price To Book2.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book2.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.60
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-18.69
Return on Equity-25.43
Return on Capital-24.40

LAVA Therapeutics N.V. (LVTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers Accountants N.V.
CEOStephen A. Hurly
Emplyoees58
Last AuditUQ
CIK0001840748
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
AddressYalelaan 60
Utrecht, UT 3584 CM
Websitehttps://www.lavatherapeutics.com
Facsimile-
Telephone+31 850163100
Email-


Your Recent History
NASDAQ
LVTX
LAVA Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.